Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid

Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Internal medicine (Tokyo, Japan) - Vol. 60, No. 1 (2021), p. 123-130

Language:

English

Contributors:

Shinoda, Masahiro
Kamachi, Kenichi
Ota, Shinichiro
Yoshimatsu, Lynn
Boku, Ryuichi
Yoshida, Yuto
Hirouchi, Takatomo
Shinada, Kanako
Sato, Takashi
Morikawa, Miwa
Iwata, Koki
Matsumoto, Takashi
Shinkai, Masaharu

Links:

Volltext

Keywords:

*Extracorporeal Membrane Oxygenation
*Respiration, Artificial
Adrenal Cortex Hormones
Aged
Amides
Antiviral Agents
COVID-19
Case Reports
Corticosteroid
EW5GL2X7E0
Extracorporeal membrane oxygenation
Favipiravir
Humans
Journal Article
Male
Mechanical ventilation
Methylprednisolone
Middle Aged
Pyrazines
Respiratory Insufficiency
SARS-CoV-2
X4W7ZR7023

Notes:

Date Completed 12.01.2021

Date Revised 12.01.2021

published: Print-Electronic

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.2169/internalmedicine.5475-20

PMID:

33390469

PPN (Catalogue-ID):

NLM32056195X